Showing results (31-40 of 289) with videos related to
Sort By:
Pageof 29
Cell|November 4, 2006
PGC-1alpha, a new therapeutic target in Huntington's disease?Jetta K McGill, M Flint BealAntioxidants & Redox Signaling|October 13, 2006
Oxidative damage in Huntington's disease pathogenesisSusan E Browne, M Flint BealFree Radical Biology & Medicine|April 10, 2013
Mitochondrial diseases of the brainRajnish K Chaturvedi, M Flint BealNeurochemistry International|February 19, 2002
Mitochondrial dysfunction in progressive supranuclear palsyDavid S Albers, M Flint BealJournal of Neurochemistry|April 4, 2008
PPAR: a therapeutic target in Parkinson's diseaseRajnish K Chaturvedi, M Flint BealNature|October 20, 2006
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseasesMichael T Lin, M Flint BealAnnals of the New York Academy of Sciences|December 17, 2008
Mitochondrial approaches for neuroprotectionRajnish K Chaturvedi, M Flint BealFASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 30, 2010
Behavioral deficits and progressive neuropathology in progranulin-deficient mice: a mouse model of frontotemporal dementiaFangfang Yin, Magali Dumont, Rebecca Banerjee, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 28, 2014
Prospects for neuroprotective therapies in prodromal Huntington's diseaseAbhishek Chandra, Ashu Johri, M Flint BealFree Radical Biology & Medicine|April 23, 2013
PGC-1α, mitochondrial dysfunction, and Huntington's diseaseAshu Johri, Abhishek Chandra, M Flint BealPageof 29